The oncologist
Journal
Overview
publication venue for
-
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.
2017
-
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.
2023
-
The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review.
2023
-
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial.
2023
-
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
2023
-
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
2023
-
Exocrine Pancreatic Insufficiency Induced by Immune Checkpoint Inhibitors.
2023
-
Specialty Differences in Medical Aid in Dying Experiences: Results of a Survey of Physicians in Colorado.
2023
-
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events..
28.
2023
-
Associations Between Race/Ethnicity, Language, and Enrollment on Cancer Research Studies..
28.
2023
-
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.
2023
-
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
2022
-
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
2022
-
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network..
27.
2022
-
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer..
27.
2022
-
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
2022
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
2022
-
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease..
26.
2021
-
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study..
26.
2021
-
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
2021
-
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
2021
-
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017.
2021
-
Prognostic Factors for Overall Survival in Patients with Hormone Receptor-Positive Advanced Breast Cancer: Analyses From PALOMA-3..
26.
2021
-
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3..
26.
2021
-
Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and Nigeria..
26.
2021
-
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma..
26.
2021
-
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure..
26.
2021
-
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19..
26.
2021
-
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors..
26.
2021
-
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up..
26.
2021
-
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma..
26.
2021
-
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series..
26.
2020
-
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study..
25.
2020
-
ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling..
25.
2020
-
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma..
25.
2020
-
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study..
25.
2020
-
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma..
25.
2020
-
Pilot Study of Hyperfractionated Dosing of Lutetium-177-Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (177 Lu-J591) for Metastatic Castration-Resistant Prostate Cancer..
25.
2020
-
Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella..
25.
2019
-
A Multidisciplinary Head-to-Head Comparison of American College of Radiology Thyroid Imaging and Reporting Data System and American Thyroid Association Ultrasound Risk Stratification Systems..
25.
2019
-
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer..
25.
2019
-
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor..
24.
2019
-
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer..
24.
2019
-
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer..
24.
2019
-
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-up..
24.
2019
-
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma..
24.
2018
-
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors..
24.
2018
-
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors..
24.
2018
-
Development and Validation of a Clinical Score for Cardiovascular Risk Stratification of Long-Term Childhood Cancer Survivors..
23.
2018
-
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors..
23.
2018
-
Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy..
23.
2017
-
Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program..
23.
2017
-
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results..
22.
2017
-
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring..
23.
2017
-
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results..
22.
2017
-
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS..
22.
2017
-
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma..
22.
2017
-
Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug..
22.
2017
-
Complete Metabolic Response on Interim 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy..
22.
2017
-
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience..
22.
2017
-
Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction..
22.
2017
-
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803..
22.
2016
-
Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma..
22.
2016
-
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone..
21.
2016
-
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction..
21.
2016
-
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)..
21.
2016
-
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma..
21.
2016
-
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis..
21.
2016
-
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer..
21.
2016
-
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer..
21.
2016
-
Sentinel Lymph Node Mapping in Endometrial Cancer: An Update..
21.
2016
-
Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy..
21.
2016
-
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas..
20.
2015
-
Susan Bates, M.D., and Antonio "Tito" Fojo, M.D., Ph.D.: Thirty Years of Research, Discovery, Service, and Mentorship at the National Cancer Institute..
20.
2015
-
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation..
20.
2015
-
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes..
20.
2015
-
Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction..
20.
2015
-
Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer..
20.
2015
-
Posterior Reversible Encephalopathy Syndrome in Patients With Cancer..
20.
2015
-
Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women..
20.
2015
-
Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review..
20.
2015
-
A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases..
20.
2015
-
Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer..
20.
2015
-
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience..
20.
2015
-
Chronic thalidomide and chemoembolization for hepatocellular carcinoma..
19.
2014
-
Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis..
19.
2014
-
Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients..
19.
2014
-
A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer..
19.
2014
-
Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer..
18.
2013
-
Ipilimumab for patients with advanced mucosal melanoma..
18.
2013
-
The NOMS framework: approach to the treatment of spinal metastatic tumors..
18.
2013
-
Toxicity of bevacizumab in combination with chemotherapy in older patients..
18.
2013
-
Analysis of dermatologic events in vemurafenib-treated patients with melanoma..
18.
2013
-
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer..
18.
2013
-
Doublet chemotherapy in the elderly patient with ovarian cancer..
17.
2012
-
Truth-telling and cancer diagnoses: physician attitudes and practices in Qatar..
17.
2012
-
A pilot randomized controlled trial of brief cognitive-behavioral therapy for anxiety in patients with terminal cancer..
17.
2012
-
The effect of age on delay in diagnosis and stage of breast cancer..
17.
2012
-
First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study..
17.
2012
-
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer..
17.
2012
-
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer..
16.
2011
-
Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy..
16.
2011
-
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions..
16.
2011
-
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice..
16.
2011
-
Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC..
16.
2011
-
Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy..
16.
2011
-
Predictive value of in vitro mutation data to guide second-generation tyrosine kinase inhibitor selection: ready for prime time?.
16.
2011
-
Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw..
16.
2011
-
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603)..
15.
2010
-
Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study..
15.
2010
-
CXCR4 expression in early breast cancer and risk of distant recurrence..
14.
2009
-
The chronology of distress, anxiety, and depression in older prostate cancer patients..
14.
2009
-
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer..
14.
2009
-
Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma..
14.
2009
-
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies..
14.
2009
-
Effects of aerobic exercise training in anemic cancer patients receiving darbepoetin alfa: a randomized controlled trial..
13.
2008
-
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy..
13.
2008
-
Prognostic value of initial clinical disease stage after achieving pathological complete response..
13.
2008
-
Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer..
12.
2007
-
Trends for inflammatory breast cancer: is survival improving?.
12.
2007
-
Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data..
11.
2006
-
Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level..
11.
2006
-
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer..
7.
2002
-
Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients..
6.
2001
-
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition..
5.
2000
-
Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology..
4.
1999
-
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer..
4.
1999
-
Adjuvant Drug Treatment for Resectable Breast Cancer..
2.
1997
-
Clinical Use of Irinotecan: Current Status and Future Considerations..
2.
1997
-
Adjuvant Chemotherapy of Colorectal Cancer..
1.
1996
-
Drug Resistance..
1.
1996
-
Next-Generation Sequencing in the Diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial Cancer Metastasis to the Brain
-
Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience..
24.
2019
-
In Reply..
23.
2018
-
In reply..
20.
2015
-
In reply.
2013
-
Breast cancer highlights: key findings from the San Antonio Breast Cancer Symposium: a U.S. perspective.
2004
-
Breaking down the evidence for bevacizumab in ovarian cancer..
20.
2015
-
Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?.
16.
2011
-
The weaknesses of science for profit..
7.
2002
-
Magnetic Resonance Imaging-Based Screening for Asymptomatic Brain Tumors: A Review.
2018
-
Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors.
2018
-
The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.
2013
-
Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow.
2011
-
Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.
2010
-
Controversies in the treatment of lymphoma with autologous transplantation.
2009
-
Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
2009
-
Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies.
2008
-
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.
2008
-
Retinoblastoma: review of current management.
2007
-
Presurgical chemotherapy in patients being considered for liver resection.
2007
-
Role of minimally invasive surgery in gynecologic cancers.
2006
-
Locally advanced pancreatic cancer: current therapeutic approach.
2006
-
The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection.
2006
-
Antibody-based therapies for colorectal cancer.
2005
-
Fertility-sparing options for patients with gynecologic malignancies.
2005
-
Targeted therapies for esophageal cancer.
2005
-
HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
2005
-
Breast cancer in African-American women.
2005
-
Complementary and alternative therapies for cancer.
2004
-
An update on hepatic arterial infusion chemotherapy for colorectal cancer.
2003
-
Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience.
2001
-
Thymoma: update for the new millennium.
2001
-
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents.
2020
-
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
2019
-
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.
2017
-
Malignant peripheral nerve sheath tumors.
2014
-
Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.
2011
-
The role of mitoxantrone in the treatment of indolent lymphomas.
2005
-
Update on the management of inflammatory breast cancer.
2003
-
The mammography controversy.
2002
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)